Skip to main content
OpenTrials
Completed

NCT Number: NCT00922077

Individualized Neurodevelopmental Treatment

The purpose of the study was to evaluate this therapeutic intervention by expressing functional level with valid quantitative data.

Completed

Looking for future studies?

Notify Me

Key information

Age range

6 year–9 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 3

Primary location

Hellenic Society for Disabled Children

Thessaloniki, THessaloniki, 25155, Greece

About this study

The intervention lasted 6 weeks. There were 3 sessions per week. At each session there was a part of standard physical therapy program and there was also a part with emphasis on dynamic balance exercises.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • spastic tetraplegia

Exclusion criteria

  • vision problems

Treatment and study plan

standard physical therapy program with emphasis on dynamic balance exercises

Behavioral

Sponsors and collaborators

Lead sponsor

Hellenic Society for Disabled Children

Other

Registry information

Important dates

Study start
2008
Primary completion
2008
Study completion
2008
First posted
Jun 17, 2009
Registry last updated
Jun 17, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.